PFIZER INC Deferred Tax Liabilities, Net, Current
PFIZER INC (PFE) had Deferred Tax Liabilities, Net, Current of $1.82 billion as of 2009-09-27, per its 10-Q filed 2009-11-05.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesCurrent · last filed 2009-11-05
- 2009-09-27: Deferred Tax Liabilities, Net, Current $1.82B.
- 2008-12-31: Deferred Tax Liabilities, Net, Current $414.00M.
| Period end | Deferred Tax Liabilities, Net, Current |
|---|---|
| 2009-09-27 | $1.82B 10-Q · filed 2009-11-05 |
| 2008-12-31 | $414.00M 10-Q · filed 2009-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |